
The 'Galleri blood test' aims to detect cancers early by looking for abnormal DNA
The NHS is to trial a ‘potentially revolutionary' blood test that could discover a range of different cancer types is to be trialled by the NHS, the national health service's chief executive Sir Simon Stevens has announced. Known as the Galleri blood test, it has been developed by the company GRAIL to spot early signs of cancer by seeking out abnormal DNA shed from cells into the blood. DNA from cancer cells often have differences in the chemical tags compared to DNA from healthy cells. ...
To continue reading this article...
Join Cover
- Unlimited access to real-time news, key trend analysis and industry insights.
- Stay on top of the latest developments around Covid-19, regulation, diversity and mental health.
- Receive breaking news stories straight to your inbox in the daily newsletter.
- Members only access to monthly programme 'The COVER Review'
- Be the first to hear about our CPD accredited events and awards programmes.